This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Fumio Higuchi: Innovator in Gel Preparation for Hyperpotassemia
Introduction
Fumio Higuchi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medical preparations, particularly in the development of gel formulations for therapeutic use.
Latest Patents
Higuchi holds a patent for a polystyrene sulfonate-containing gel preparation. This invention is designed for the therapy of hyperpotassemia. The gel preparation features controlled particle sizes of polystyrene sulfonate, ranging from 5 to 100 µm. The viscosity of the solution before gelation is adjusted by adding a thickening agent, depending on the particle size. After gelation, the polystyrene sulfonate particles are uniformly dispersed within the gel. Additionally, the preparation may contain a water-displacing agent, which reduces the water content, making it easier for patients with renal insufficiency to manage their water intake. This innovative gel does not create a sense of foreign matter or roughness in the oral cavity, allowing for easier ingestion without the need for additional water.
Career Highlights
Fumio Higuchi is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing research and development in medical formulations. His work has significantly improved the quality of life for patients requiring careful management of their water intake.
Collaborations
Higuchi has collaborated with notable colleagues, including Hideaki Ninomiya and Masahiro Nakajima. Their combined expertise has contributed to the successful development of innovative medical solutions.
Conclusion
Fumio Higuchi's contributions to the field of gel preparations for hyperpotassemia highlight his innovative spirit and dedication to improving patient care. His work continues to influence the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile